Olfr631 is a member of the olfactory receptor family, which plays a crucial role in the detection and discrimination of a vast array of odorant molecules. Situated in the olfactory epithelium, these receptors are expressed on the surface of olfactory sensory neurons, forming an intricate network that facilitates the recognition of diverse chemical stimuli. Olfr631, like other olfactory receptors, is fundamental to the process of odor perception, wherein it contributes to the transduction of odor signals into neural impulses. The functional significance of Olfr631 lies in its ability to recognize and respond to specific odorants, thereby initiating a cascade of intracellular events that ultimately result in the perception of distinct smells.
Inhibition of Olfr631 involves intricate cellular and molecular mechanisms targeting various aspects of olfactory signal transduction. Chemical inhibitors act on key signaling pathways and molecules associated with olfactory receptor function. For instance, compounds that enhance cAMP levels indirectly inhibit Olfr631 by prolonging the activation of olfactory receptors, influencing downstream signaling events. Inhibition may also occur through modulation of intracellular kinases or phosphatases that participate in the olfactory transduction cascade. Additionally, epigenetic modifiers alter the expression of olfactory receptor genes, including Olfr631, by modifying chromatin structure. The disruption of calcium channels or G-protein signaling also contributes to the inhibition, affecting the overall sensitivity and responsiveness of olfactory sensory neurons. These diverse mechanisms collectively orchestrate the inhibition of Olfr631, reflecting the intricate interplay of molecular events involved in olfactory signal processing.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Selective PDE4 inhibitor targeting cAMP degradation. Modulates olfactory signaling by enhancing intracellular cAMP levels, indirectly inhibiting Olfr631. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $112.00 $163.00 $928.00 | 19 | |
Inhibits the MEK-ERK pathway, impacting downstream signaling. Indirectly influences Olfr631 function by modulating intracellular signaling dynamics. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Enhances adenylyl cyclase activity, increasing cAMP production. Indirectly influences Olfr631 by promoting intracellular signaling through cAMP. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Blocks HDAC activity, influencing chromatin structure. Indirectly modulates Olfr631 expression by altering epigenetic regulation of the olfactory receptor gene. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Inhibits PKC signaling, impacting olfactory receptor activation. Indirectly influences Olfr631 function by modulating downstream signaling pathways. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Blocks calcium channels, affecting intracellular signaling. Indirectly inhibits Olfr631 by disrupting calcium-dependent processes in olfactory transduction. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Selective G-protein inhibitor targeting olfactory signaling. Modulates receptor activation, indirectly influencing Olfr631 function in the olfactory system. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Modifies epigenetic marks, influencing olfactory receptor gene expression. Indirectly modulates Olfr631 by altering the epigenetic regulation of the gene. | ||||||
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $75.00 $150.00 $235.00 | 8 | |
Uncouples mitochondrial oxidative phosphorylation. Indirectly influences Olfr631 by altering cellular energy metabolism and signaling dynamics. | ||||||